Avinger, inc. announces closing of $5 million registered direct and private placement offerings priced at-the-market under nasdaq rules

Redwood city, ca / accesswire / august 8, 2022 / avinger, inc. (nasdaq:avgr) (the "company"), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the closing of its previously announced registered direct and private placement offerings priced at-the-market under nasdaq rules, including the issuance and sale of (i) 700,000 shares of common stock and 784,019 pre-funded warrants in the registered direct offering and (ii) 1,369,864 pre-funded warrants in the private placement. the gross proceeds to avinger from the offerings are approximately $5 million, before deducting placement agent fees and other offering expenses.
AVGR Ratings Summary
AVGR Quant Ranking